stockmarketproxy
/
AVTRNYSESEC EDGAREDGAR

Avantor, Inc.

Laboratory Analytical Instruments·RADNOR, PA·FY end 12/31·CIK 1722482
OverviewFinancialsCompensationGovernanceInsidersFilings

Financials

5-year history · USD
MetricFY 2025FY 2024FY 2023FY 2022FY 2020Trend
Revenue$6.6B$6.8B$7.0B$7.5B$7.4B
Gross Profit$2.1B$2.3B$2.4B$2.6B$2.5B
Operating Income-$246.2M$1.1B$696.4M$1.1B$972.2M
Net Income-$530.2M$711.5M$321.1M$686.5M$572.6M
Operating CF$623.8M$840.8M$870.0M$843.6M$953.6M
Capex$128.8M$148.8M$146.4M$133.4M$111.1M
Free Cash Flow$495.0M$692.0M$723.6M$710.2M$842.5M
Buybacks$75.1M—————
Dividends——————
Gross Margin32.7%33.6%33.9%34.6%33.9%
Operating Margin-3.8%16.0%10.0%15.0%13.2%
Net Margin-8.1%10.5%4.6%9.1%7.8%
FCF Margin7.6%10.2%10.4%9.5%11.4%
R&D / Revenue——————
Effective Tax-20.1%16.7%21.8%19.3%24.0%
Debt / Equity1.411.222.062.513.34
Buybacks / FCF15.2%—————

Peer comparison

Laboratory Analytical Instruments · 5 peers
CEO Pay Ratio
AVTR
148:1
RVTY
239:1
ILMN
97:1
BIO
97:1
MTD
118:1
A
155:1
CEO total comp
AVTR
$6M
RVTY
$14M
ILMN
$11M
BIO
$8M
MTD
$7M
A
$0M
Net Margin
AVTR
-8.1%
RVTY
8.4%
ILMN
19.6%
BIO
29.4%
MTD
21.6%
A
18.8%